Dr. Jacob Scott Ankeny, MD

Dr. Ankeny practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Ankeny's NPI, 1841518032, was assigned on May 12, 2010. Dr. Ankeny graduated from University of Minnesota, Duluth School of Medicine in 2010. Dr. Ankeny holds Minnesota license 65631.

Dr. Ankeny's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Ankeny's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Ankeny is also affiliated with M Health Fairview St. John's Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Ankeny to 1 more hospital, 5 group practices and clinics, 5 medical groups, 1 dialysis center and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ankeny practices, 10 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Ankeny's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Ankeny's licenses on file in 2 states: Minnesota and Florida.

CMS data shows 12 Medicare services from Dr. Ankeny across 1 procedure code in 2024, all of them office visits, for 34 Medicare patients. Medicare paid $1,101 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 34 Medicare patients who saw Dr. Ankeny in 2024. The largest group is 75 to 84, with 12 patients. 74% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ankeny's median patient age at 69, with 52% women.

In 2024, Dr. Ankeny wrote 15 Medicare Part D claims. 80% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $27 in total drug cost. In 2018, CMS named 61 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Ankeny for performance year 2024, reported as part of a group. Dr. Ankeny accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ankeny as offering telehealth.

Dmand AI links 18 papers to Dr. Ankeny, published from 2013 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Chemotherapy, Adjuvant, Lymph Node Excision and Lymph Nodes. Dr. Ankeny has published most often in Breast Cancer Res Treat. Dr. Ankeny's most frequent co-authors are Eric Hans Jensen, MD, Todd Michael Tuttle, MD and James Samuel Tomlinson, MD.

CMS Open Payments shows 6 general payments to Dr. Ankeny from 3 drug and device companies from 2020 to 2023. Travel and lodging make up the largest share, 77% of the total. Stryker Corporation paid the most, $844.

Dr. Ankeny graduated from University of Minnesota, Duluth School of Medicine in 2010.